关注
Elizabeth (Betsy) Charron
Elizabeth (Betsy) Charron
University of Oklahoma Health Sciences Center
在 ouhsc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Validation and threshold identification of a prescription drug monitoring program clinical opioid risk metric with the WHO alcohol, smoking, and substance involvement screening …
G Cochran, J Brown, Z Yu, S Frede, MA Bryan, A Ferguson, N Bayyari, ...
Drug and alcohol dependence 228, 109067, 2021
192021
“It’sa very nuanced discussion with every woman”: Health care providers’ communication practices during contraceptive counseling for patients with substance use disorders
E Charron, RM Mayo, SF Heavner-Sullivan, KY Eichelberger, L Dickes, ...
Contraception 102 (5), 349-355, 2020
172020
Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014
J Summey, L Chen, R Mayo, E Charron, JA Hudson, WW Sherrill, ...
The Joint Commission Journal on Quality and Patient Safety 44 (6), 312-320, 2018
112018
Provider perspectives of barriers to contraceptive access and use among women with substance use disorders
E Charron, F Tahsin, R Balto, KY Eichelberger, L Dickes, SE Simonsen, ...
Women's Health Issues 32 (2), 165-172, 2022
92022
Baby-friendly hospital initiative is associated with lower rates of neonatal hyperbilirubinemia
JA Hudson, E Charron, B Maple, M Krom, SF Heavner-Sullivan, RM Mayo, ...
Breastfeeding Medicine 15 (3), 176-182, 2020
92020
Using data science to improve outcomes for persons with opioid use disorder
CJ Hayes, MA Cucciare, BC Martin, TJ Hudson, K Bush, W Lo-Ciganic, ...
Substance abuse 43 (1), 956-963, 2022
72022
Disparities in access to mental health services among patients hospitalized for deliberate drug overdose
E Charron, EC Francis, SF Heavner-Sullivan, KD Truong
Psychiatric services 70 (9), 758-764, 2019
72019
Treatment access for opioid use disorder in pregnancy among rural and American Indian communities
AT Kelley, MC Smid, JD Baylis, E Charron, LJ Begaye, A Binns-Calvey, ...
Journal of Substance Abuse Treatment 136, 108685, 2022
62022
Prospective acceptability of digital phenotyping among pregnant and parenting people with opioid use disorder: A multisite qualitative study
E Charron, A White, K Carlston, W Abdullah, JD Baylis, S Pierce, ...
Frontiers in Psychiatry 14, 1137071, 2023
52023
Associations between elevated depressive symptoms and substance use, prescription opioid misuse, overdose history, pain, and general health among community pharmacy patients …
JL Brown, G Cochran, MA Bryan, E Charron, TJ Winhusen
Substance abuse 43 (1), 1110-1115, 2022
52022
Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities
AT Kelley, MC Smid, JD Baylis, E Charron, AE Binns-Calvey, S Archer, ...
Addiction Science & Clinical Practice 16 (1), 40, 2021
42021
Third trimester maternal vitamin D and early childhood socioemotional development
EC Francis, E Charron, M Li, L Chen, R Mayo, LS Butler, L Rennert
Paediatric and perinatal epidemiology 35 (3), 350-358, 2021
42021
Cluster analysis to identify patient profiles and substance use patterns among pregnant persons with opioid use disorder
E Charron, Z Yu, B Lundahl, J Silipigni, A Okifuji, AJ Gordon, JD Baylis, ...
Addictive Behaviors Reports 17, 100484, 2023
32023
Barriers to and facilitators of hormonal and long-acting reversible contraception access and use in the US among reproductive-aged women who use opioids: A scoping review
E Charron, J Kent-Marvick, T Gibson, E Taylor, K Bouwman, GM Sani, ...
Preventive Medicine Reports 32, 102111, 2023
32023
Pain severity and interference and substance use among community pharmacy patients prescribed opioids: a secondary analysis of the PHARMSCREEN Study
E Charron, A Okifuji, MA Bryan, S Reese, JL Brown, A Ferguson, ...
The journal of pain 23 (8), 1448-1459, 2022
32022
Contraceptive initiation after delivery among women with and without opioid use disorders: a retrospective cohort study in a statewide Medicaid population, 2005–2016
E Charron, L Rennert, RM Mayo, KY Eichelberger, L Dickes, KD Truong
Drug and Alcohol Dependence 220, 108533, 2021
32021
Managing Abstinence in Newborns (MAiN): Redesigning NAS care for the mother/baby unit
J Hudson, E Charron, J Bedi, L Dickes, R Mayo, WW Sherrill
Healthcare 8 (1), 100404, 2020
32020
Patient navigation for pregnant individuals with opioid use disorder: Results of a randomized multi‐site pilot trial
G Cochran, MC Smid, EE Krans, Z Yu, K Carlston, A White, W Abdulla, ...
Addiction 119 (3), 544-556, 2024
22024
Attitudes, self-efficacy, and practices related to opioid risk assessment and mitigation: A comparison of health care professionals in rural communities
JD Baylis, E Charron, S Archer, M Garets, MA Bryan, J Foringer, AT Kelley, ...
Substance Abuse 43 (1), 1163-1171, 2022
22022
Concomitant cannabis misuse and associations with depression, pain and substance misuse among patients prescribed opioids
MA Bryan, E Charron, O Adeoye-Olatunde, J Brown, U Ghitza, ...
Pharmacy 9 (3), 134, 2021
22021
系统目前无法执行此操作,请稍后再试。
文章 1–20